Internal Medicine, Rheumatology · Wilkes Barre, PA
NPI
1548225543
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
675 Baltimore Dr
Wilkes Barre, PA, 18702
Phone (570) 808-6111
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
1,178 services
Medicare patients, 2024
352
Average age 71
Drug cost, 2024
$8.6M
5,088 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Pugliese was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 272 times for 214 patients. In total David M Pugliese billed 1,178 services in 20 codes, and Medicare paid $42K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 272 | 214 | $11.84 | $3,221 |
| 99214 Office E&M - Established | Office | 239 | 190 | $67.30 | $16K |
| 20610 Joint Injection | Office | 94 | 47 | $38.88 | $3,655 |
| 99213 Office E&M - Established | Office | 90 | 80 | $51.86 | $4,667 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 71 | 53 | $12.12 | $861 |
| 99214 Office E&M - Established | Facility | 69 | 50 | $66.83 | $4,611 |
| 99205 Office E&M - New | Office | 37 | 37 | $122.46 | $4,531 |
| 99213 Office E&M - Established | Facility | 20 | 17 | $49.88 | $998 |
By year: 2022 $35K for 564 services; 2023 $37K for 604 services; 2024 $42K for 1,178 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Pugliese prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 974 prescriptions and refills. In total David M Pugliese wrote 5,088 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 974 | 2,426 | 283 | $49K |
| Prednisone Generic | 473 | 693 | 204 | $4,136 |
| Methotrexate Methotrexate Sodium | 391 | 901 | 126 | $14K |
| Gabapentin Generic | 251 | 503 | 69 | $5,083 |
| Leflunomide Generic | 242 | 530 | 69 | $15K |
| Rinvoq Upadacitinib | 221 | 221 | 33 | $1.4M |
| Humira Pen Adalimumab | 221 | 221 | 38 | $1.8M |
| Xeljanz Xr Tofacitinib Citrate | 169 | 177 | 27 | $992K |
| Allopurinol Generic | 126 | 276 | 43 | $1,984 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 119 | 119 | 13 | $1,867 |
| Alendronate Sodium Generic | 117 | 270 | 36 | $1,108 |
| Enbrel Sureclick Etanercept | 91 | 100 | 17 | $657K |
| Tizanidine Hcl Generic | 80 | 114 | 14 | $1,063 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 68 | 68 | Under 11 | $1,899 |
| Cimzia (2 Pack) Certolizumab Pegol | 68 | 72 | 12 | $406K |
Brand drugs: - claims; generic drugs: 3,718 claims; opioid claims: 275.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David M Pugliese were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.